TEleRehabilitation foR Aphasia (TERRA) phase II trial design
This paper details the design of the TERRA trial, which aims to test whether aphasia therapy delivered by a remote speech-language pathologist through videoconferencing (i.e., via telerehabilitation) is not clinically worse than in-clinic therapy for individuals with chronic post-stroke aphasia to provide an opportunity to move to a definitive phase III trial.
Authors
- Dirk‐Bart den Ouden (ORCID: https://orcid.org/0000-0001-6971-7606)
- Julius Fridriksson (ORCID: https://orcid.org/0000-0001-9255-2045)
- Argye E. Hillis (ORCID: https://orcid.org/0000-0002-5192-1171)
- Heather Shaw Bonilha (ORCID: https://orcid.org/0000-0002-3581-4202)
- Jordan Elm (ORCID: https://orcid.org/0000-0002-4893-8474)
- Gregory Hickok
- Alexandra Basilakos (ORCID: https://orcid.org/0000-0003-0053-1082)
- Chris Rorden (ORCID: https://orcid.org/0000-0002-7554-6142)
- Janina Wilmskoetter (ORCID: https://orcid.org/0000-0002-1083-7301)
- Christy Cassarly (ORCID: https://orcid.org/0000-0002-0304-9833)
- Lisa Johnson (ORCID: https://orcid.org/0000-0002-8739-828X)
Institutions
- Johns Hopkins University (US)
- Medical University of South Carolina (US)
- University of South Carolina (US)
- University of California, Irvine (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.conctc.2024.101406
- Citations
- 1
- Primary Topic
- Neurobiology of Language and Bilingualism
- Type
- article
- Field-Weighted Citation Impact
- 0.34
Funders
- National Institutes of Health
- National Institute on Deafness and Other Communication Disorders